This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
Occupational skin diseases (OSD) are common and costly. They represent the second most common type of occupational illness and include irritant contact dermatitis, allergic contact dermatitis, skin cancers and skin infections. Just one OSD — contact dermatitis – has estimated annual costs of more than $1 billion. Plus, health problems caused by toxins absorbed through the skin can be more than skin deep; dermal exposure to hazardous agents can enter the blood stream and affect other parts of the body.1
Despite this, efforts to minimize workers’ exposure to toxins have long focused mainly on the inhalation route. Fortunately, NIOSH has developed a hierarchy of controls to reduce dermal exposure.